A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients with Chronic Motor Deficit from Traumatic Brain Injury (TBI) Save

Date Added
May 10th, 2016
PRO Number
Pro00048268
Researcher
Istvan Takacs

Silhouette
Keywords
Brain
Summary

You are invited to volunteer for a research study if you have been diagnosed with a persistent arm or leg weakness from a traumatic brain injury (TBI), which was caused by an injury to the head at least 12 months ago, but not more than 36 months ago

This study will determine the safety and usefulness of a suspension of SB623 cells administered by injection around the area of injury in your brain. SB623 is made of modified stem cells taken from the bone marrow of another adult human. SB623 cells are investigational, but they have been shown to secrete (give off) agents that may be helpful to injured brain tissue.

Institution
MUSC
Recruitment Contact
Michele DeCandio
843-792-9016
decandio@musc.edu

Change_preferences

-- OR --

Create_login